Request Demo
Last update 13 Oct 2025
Recibokibart
Last update 13 Oct 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms Recombinant humanized anti-interleukin 36R monoclonal antibody(Huaota Biopharma), HB 0034, HB0034 |
Target |
Action inhibitors |
Mechanism IL-36R inhibitors(Interleukin-36 receptor inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
RegulationPriority Review (United States), Orphan Drug (United States), Priority Review (China) |
Login to view timeline
Structure/Sequence
Sequence Code 941453118H
Source: *****
Sequence Code 941453119L
Source: *****
Related
7
Clinical Trials associated with RecibokibartNCT06716151
A Phase I, Randomized, Double-blind, Placebo-controlled, Single/mulit Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HB0034 in Adult Healthy Subjects
NCT06477536
A Phase IIb, Long-Term Extension Study to Evaluate the Safety and Efficacy of HB0034 in the Treatment of Adult Subjects With Generalized Pustular Psoriasis
CTR20242844
评价HB0034在泛发性脓疱型银屑病患者中安全性和疗效的多中心、单臂、开放标签IIb期长期安全扩展研究
[Translation] A multicenter, single-arm, open-label, phase IIb long-term safety extension study to evaluate the safety and efficacy of HB0034 in patients with generalized pustular psoriasis
100 Clinical Results associated with Recibokibart
Login to view more data
100 Translational Medicine associated with Recibokibart
Login to view more data
100 Patents (Medical) associated with Recibokibart
Login to view more data
1
Literatures (Medical) associated with Recibokibart01 Jun 2025JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Recibokibart, an anti‐IL ‐36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial
Letter
Author: Zhang, Furen ; Zhang, Chunlei ; Chen, Jiaqi ; Ma, Xiuqiang ; Zhan, Yifan ; Lu, Xueyan ; Ma, Chi ; Man, Xiaoyong ; Kuang, Yehong ; Yang, Yongming ; Qian, Qiaoxia ; Zhang, Zhaoxia ; Situ, Xiaolu ; Li, Benke ; Yang, Baoqi ; Zhu, Xiangyang ; Chen, Shi ; Zhou, Guodong ; Su, Juan ; Wang, Jiucun ; Chen, Qian ; Feng, Yujie
100 Deals associated with Recibokibart
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Generalized Pustular Psoriasis | NDA/BLA | China | 01 Oct 2025 | |
| Generalized Pustular Psoriasis | NDA/BLA | China | 01 Oct 2025 | |
| Colitis, Ulcerative | Phase 3 | China | - | |
| Systemic Lupus Erythematosus | Phase 3 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 9 | uyuvbrozag(vcenwfpsdq) = zjizxyutnj xbvubbzyst (ppamjiedck ) | Positive | 11 Oct 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free